Drugs News and Research

RSS

Cancer neuroscience: A new frontier in cancer treatment

Cancer cells hijack normal biological processes, allowing them to multiply. For example, tumors spur construction of new blood vessels, building themselves "highways" to supply nutrients.

1 Nov 2023

Study highlights disparities in stroke care across socioeconomic groups

People who live in neighborhoods with lower socioeconomic status are less likely to receive clot-busting medications or undergo clot-removing procedures after they have a stroke than people who live in neighborhoods with higher socioeconomic status, according to a study published in the November 1, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

1 Nov 2023

Clinical trial demonstrates the effectiveness of ALS drug in treating people with acute spinal cord injuries

A small clinical trial with a pharmacokinetic sub-study, led by a world-renowned pharmacologist at the University of Houston, has demonstrated the promising effectiveness of the drug Riluzole for improving functionality in people with acute spinal cord injuries (SCI) if the drug is taken within 12 hours post-injury.

1 Nov 2023

JAK inhibitors offer effective and convenient treatment option for arthritis patients

According to a new paper in Rheumatology, published by Oxford University Press, JAK inhibitors, which doctors have used to treat patients with arthritis despite concerns about the effectiveness of such drugs, actually do work quite well.

1 Nov 2023

New drug shows promise in killing cancer cells with genetic vulnerability

Imagine the body's cells are well-behaved students in the classroom. The "teachers" are tumor suppressor genes, and they make sure cells follow the rules. But when tumor suppressor genes are away, cells may go astray.

1 Nov 2023

New gene editing method creates first mice with human-like COVID-19

Researchers have genetically engineered the first mice that get a human-like form of COVID-19, according to a study published online November 1 in Nature.

1 Nov 2023

Does the percentage of slow-wave sleep decline with aging, and are intra-individual declines associated with dementia risk?

Researchers investigated whether slow-wave sleep (SWS) proportions reduced as individuals aged and whether intra-individual decreases were linked to dementia risk.

1 Nov 2023

Managing menopause: The 2023 toolkit for healthcare practitioners

The authors of the revised 2023 Toolkit extracted key recommendations from professional guidelines and positions as well as consensus statements on menopause and related conditions that have emerged since 2014.

1 Nov 2023

Medical school on Cherokee reservation will soon send doctors to tribal, rural areas

Ashton Glover Gatewood decided to give medical school a second try after learning about a new campus designed for Indigenous students like herself.

1 Nov 2023

Gubernatorial candidates quarrel over glory for winning opioid settlements

Opioid settlement cash is not inherently political. It's not the result of a law passed by Congress nor an edit to the state budget. It's not taxpayer money. Rather, it's coming from health care companies that were sued for fueling the opioid crisis with prescription painkillers.

1 Nov 2023

From Cells to Drugs: How Cell Painting is Transforming Drug Discovery

In this interview, Jordi Carreras delves into the fascinating world of Cell Painting, a powerful technology gaining momentum in drug discovery. He shares insights into his groundbreaking research, the unique aspects of Phenaros' drug discovery platform, and the synergy between academia and industry.

From ELRIG (UK) Ltd. 1 Nov 2023

New AI tool could lead to precision medicine by predicting drug response

An ideal medicine for one person may prove ineffective or harmful for someone else, and predicting who could benefit from a given drug has been difficult.

31 Oct 2023

World's first living brain metastasis biobank paves way for personalized cancer treatment

At 18 Spanish hospitals, when a patient with brain metastasis undergoes surgery, they can donate a tiny part of their brain to the first repository of brain metastasis living samples in the world, based at CNIO (Spanish National Cancer Research Centre).

31 Oct 2023

New drug gets FDA approval for the treatment of common genetic disease in young boys

A new drug developed by professors from the School of Pharmacy and Pharmaceutical Sciences at Binghamton University has received Food and Drug Administration (FDA) approval for the treatment of patients with Duchenne muscular dystrophy (DMD), a common genetic disease that mostly affects young boys.

31 Oct 2023

Antibiotics no longer effective in treating childhood infections in large parts of the world

Drugs to treat common infections in children and babies are no longer effective in large parts of the world, due to high rates of antibiotic resistance.

31 Oct 2023

What is the course and stability of maternal depressive symptoms throughout the perinatal period?

Researchers examined maternal depressive symptoms in diverse observational cohorts.

31 Oct 2023

University of Cincinnati to lead NIH StrokeNet for next five years

The University of Cincinnati and UC Health have been renewed as the National Coordinating Center of the National Institutes of Health (NIH) StrokeNet, which is the primary infrastructure for multicenter trials of stroke funded by NIH and the pipeline for new potential treatments for adults and children with stroke and those at risk for stroke.

30 Oct 2023

Drugs News and Research

Cancer neuroscience: A new frontier in cancer treatment

Study highlights disparities in stroke care across socioeconomic groups

Clinical trial demonstrates the effectiveness of ALS drug in treating people with acute spinal cord injuries

JAK inhibitors offer effective and convenient treatment option for arthritis patients

New drug shows promise in killing cancer cells with genetic vulnerability

New gene editing method creates first mice with human-like COVID-19

Does the percentage of slow-wave sleep decline with aging, and are intra-individual declines associated with dementia risk?

Managing menopause: The 2023 toolkit for healthcare practitioners

Medical school on Cherokee reservation will soon send doctors to tribal, rural areas

Gubernatorial candidates quarrel over glory for winning opioid settlements

From Cells to Drugs: How Cell Painting is Transforming Drug Discovery

New AI tool could lead to precision medicine by predicting drug response

World's first living brain metastasis biobank paves way for personalized cancer treatment

New drug gets FDA approval for the treatment of common genetic disease in young boys

Antibiotics no longer effective in treating childhood infections in large parts of the world

What is the course and stability of maternal depressive symptoms throughout the perinatal period?

University of Cincinnati to lead NIH StrokeNet for next five years

Scientists identify mechanism causing deadly blood clots after some COVID-19 vaccines

UQ's drug discovery facility opens to researchers nationwide after $1.9M funding injection

Study provides deeper insight into safety of COVID-19 vaccines for couples planning pregnancy

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News